| Literature DB >> 35381904 |
David Berger1, Olivier Wigger2,3, Stefano de Marchi2, Martin R Grübler2, Andreas Bloch4,5, Reto Kurmann2,6, Odile Stalder7, Kaspar Felix Bachmann4,5,8, Stefan Bloechlinger4,2,3.
Abstract
BACKGROUND: Echocardiographic parameters of diastolic function depend on cardiac loading conditions, which are altered by positive pressure ventilation. The direct effects of positive end-expiratory pressure (PEEP) on cardiac diastolic function are unknown.Entities:
Keywords: Diastolic function; Echocardiography; End-diastolic pressure; End-systolic pressure; Mechanical ventilation; Positive end-expiratory pressure; Volume relationship
Mesh:
Year: 2022 PMID: 35381904 PMCID: PMC9151717 DOI: 10.1007/s00392-022-02014-1
Source DB: PubMed Journal: Clin Res Cardiol ISSN: 1861-0684 Impact factor: 6.138
Fig. 1Exemplary loop family from a caval occlusion maneuver with the INCA device, recorded at a PEEP level of 10 cmH2O. The loop family corresponds to the echocardiography shown in Fig. 5
Fig. 5Exemplary echocardiography tracings at a PEEP level of 10 cm H2O. The frames that correspond to the PV-Loop family in Fig. 1 are shown. The left panel shows a transmitral pulsed wave Doppler trace, the right panel a tissue Doppler tracing
Characteristics of the study population
| Patients | 25 | |
|---|---|---|
| Age | (years) | 60.1 ± 6.3 |
| Female gender | 7 (28) | |
| Height | (cm) | 170 ± 7 |
| Weight | (kg) | 78 ± 12 |
| Body surface area | (m2) | 1.9 ± 0.2 |
| Oxygen consumption, calculated [ | (ml/min) | 236 ± 19 |
| Co-morbidities | ||
| Arterial hypertension | 16 (64) | |
| Coronary heart disease | 8 (32) | |
| Chronic renal insufficiency | 2 (8) | |
| Diabetes mellitus | 4 (16) | |
| COPD | 1 (4) | |
| OSAS | 4 (16) | |
| Medication | ||
| Beta blocker | 5 (20) | |
| ACE-Inhibitor / ATII-Antagonist | 14 (56) | |
| Ca2+-Antagonist | 6 (24) | |
| Inhalation therapy | 1(4) | |
| Laboratory values | ||
| Hemoglobin | (g/l) | 133 ± 10 |
| eGFR | ml/min | 81 ± 17 |
Data are given as mean ± SD or n (%)
COPD chronic obstructive pulmonary disease, OSAS obstructive sleep apnea syndrome, ACE angiotensin-converting enzyme, ATII angiotensin II, eGFR estimated glomerular filtration rate (calculated using the KDIGO CKD-EPI formula)
Baseline hemodynamic data
| Positive end-expiratory pressure | Friedman ANOVA | |||||
|---|---|---|---|---|---|---|
| 0 cmH2O | 5 cmH2O | 10 cmH2O | ||||
| Hemodynamic data | ||||||
| Non-invasive blood pressure | ||||||
| Systolic | mmHg | 24 | 125 (98–153) | 130 (103–158) | 127 (94–152) | 0.384 |
| Diastolic | mmHg | 24 | 67 (50–88) | 68 (55–108) | 68 (46–81) | 0.81 |
| Mean | mmHg | 24 | 88 (71–106) | 86 (70–125) | 86 (61–105) | 0.587 |
| Heart rate | min−1 | 25 | 68 (51–85) † | 65 (50–89) | 63 (49–85) | |
| Cardiac output | ||||||
| Thermodilution | l/min | 25 | 6.5 (3.6–9.0)*,† | 5.8 (3.7–8.0) | 5.8 (3.5–8.0) | |
| Fick principle | l/min | 25 | 5.4 (3.7–7.4) | 5.4 (3.1–7.7) | 5.2 (3.8–7.6) | 0.069 |
| Esophageal pressure | mmHg | 25 | 7.4 (1.6–34)*,† | 9.1 (3.8–62)‡ | 10.2 (1.25–20.9) | |
| Mean pulmonary artery pressure | mmHg | 24 | 17.8 (11.1–42.1) | 19.2 (13.2–34.9) | 18.3 (13.8–32.5) | 0.687 |
| Mean pulmonary artery occlusion pressure | mmHg | 24 | 9.4 (5.6–15.4)*,† | 11.6 (7.9–16.6) | 11.9 (6.2–18.8) | |
| Pulmonary vascular resistance | WU | 25 | 1.36 ± 0.64 | 1.33 ± 0.51 | 1.36 ± 0.51 | 0.933§ |
| Left ventricle | ||||||
| EDV biplane | ml | 18 | 109 (64–142) | 117 (69–148) | 115 (61–166) | 0.157 |
| ESV biplane | ml | 18 | 36 (22–64) | 37 (29–63) | 36 (24–82) | 0.799 |
| EF Simpson | % | 18 | 65 (55–75) | 67 (50–74) | 64 (51–71) | 0.498 |
| SV biplane | ml | 18 | 75 (42–92) | 75 (34–99) | 72 (37–85) | 0.101 |
| Right ventricle | ||||||
| S' tricuspid valve | m/s | 19 | 0.12 (0.09–0.21) | 0.11 (0.08–0.23) | 0.12 (0.08–0.17) | 0.416 |
| TAPSE | cm | 25 | 2.46(1.93– 3.26)*,† | 2.3(1.93–3.0)‡ | 2.13 (1.66–3.0) | |
| Blood oxygen saturation | ||||||
| Left ventricular, SaO2 | % | 25 | 95 (90–98)*,† | 96 (92–99) | 96 (92–100) | |
| Mixed venous, SmvO2 | % | 25 | 71.5 (63–78) | 71 (64–98) | 72 (64–79) | 0.648 |
p < 0.05, post-hoc Wilcoxon test: *0 vs. 5 cmH2O, †0 vs. 10 cmH2O, ‡5 vs. 10 cmH2O PEEP. §Normal distribution, one-way repeated-measures ANOVA
ANOVA analysis of variance, WU Wood units, EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, SV systolic volume, TAPSE tricuspid annular plane systolic excursion
p-values ≤0.05 were considered statistically significant and are indicated bold
Systolic impedance catheter data and ventriculo-aortic coupling
| Positive end-expiratory pressure | Friedman | |||||
|---|---|---|---|---|---|---|
| 0 cmH2O | 5 cmH2O | 10 cmH2O | p value | |||
| Systolic function and inotropy | ||||||
| Ejection fraction | % | 25 | 69 ± 9 | 67 ± 9 | 69 ± 7 | 0.163* |
| End-systolic pressures | mmHg | 25 | 123 ± 17 | 128 ± 20 | 126 ± 19 | 0.384* |
| D | mmHg/sec | 25 | 1252 ± 180 | 1230 ± 150 | 1206 ± 154 | 0.121* |
| Coupling | ||||||
| Aortic elastance | mmHg/ml | 25 | 1.16 ± 0.33 | 1.16 ± 0.37 | 1.14 ± 0.30 | 0.831* |
| Ventriculo-arterial coupling | 25 | 1.95 (1.12 to 2.78) | 1.88 (0.96–4.37) | 1.99 (1.25 to 3.29) | 0.326 | |
| Stroke work | ||||||
| Stroke work | mL*mmHg | 10,818 ± 2773 | 11,190 ± 2085 | 10,932 ± 2202 | 0.589* | |
| Preload recruitable stroke work | mmHg | 69 + 11 | 67 ± 10 | 64 ± 10 | 0.420* | |
The pressure reference is to atmosphere
*Normal distribution, one-way repeated measurements analysis of variance
Linear mixed-effect model with interactions for ESPVR
| Coefficients | Std. err | 95% confidence interval | |||
|---|---|---|---|---|---|
| ESPVR (atmospheric reference) | |||||
| Intercept for PEEP 0 cmH2O at mean volume (50.4 mL) | 123.79 | 5.58 | < 0.001 | 112.85 to 134.72 | |
| PEEP 5 cmH2O | − 3.94 | 0.82 | < 0.001 | − 5.55 to − 2.32 | |
| PEEP 10 cmH2O | 2.24 | 0.89 | 0.012 | 0.49 to 3.97 | |
| 1.05 | 0.11 | < 0.001 | 0.85 to 1.26 | ||
| PEEP 5 cmH2O | 0.07 | 0.04 | 0.07 | − 0.01 to 0.15 | |
| PEEP 10 cmH2O | 0.20 | 0.05 | < 0.001 | 0.10 to 0.29 | |
| ESPVR (transmural pressure) | |||||
| Intercept for PEEP 0 cmH2O at mean volume (50.4 mL) | 117.08 | 5.42 | < 0.001 | 106.46 to 127.70 | |
| PEEP 5 cmH2O | − 6.46 | 0.91 | < 0.001 | − 8.25 to − 4.68 | |
| PEEP 10 cmH2O | − 0.66 | 0.98 | 0.50 | − 2.58 to 1.27 | |
| 0.98 | 0.11 | < 0.001 | 0.77 to 1.19 | ||
| PEEP 5 cmH2O | 0.06 | 0.04 | 0.18 | − 0.03 to 0.15 | |
| PEEP 10 cmH2O | 0.19 | 0.05 | 0.001 | 0.08 to 0.30 | |
All interactions except 5 cmH2O PEEP are significant
ESPVR end-systolic pressure volume relationship, PEEP positive end-expiratory pressure
Fig. 2Mean left (a) and left transmural (b) ventricular pressures following an exponential decay model during isovolumetric relaxation, with 95% confidence intervals as dashed lines, resampled for 35 samples (140 ms). All data from all patients are included. PEEP, positive end-expiratory pressure
Diastolic impedance catheter and modeled pressure decay
| Positive end-expiratory pressure | Friedman ANOVA | |||||
|---|---|---|---|---|---|---|
| 0 cmH2O | 5 cmH2O | 10 cmH2O | ||||
| tau analysis | ||||||
| ms | 25 | 43.6 (35.2–57.4)*,† | 44.3 (33.7–58.7) | 44 (34.2–58.5) | ||
| ms | 25 | 46.8 (39.4–87.7)* | 49.6 (41.1–75.3) | 48.7 (37.5–70.8) | ||
| ms | 25 | 28.7 (23.9–36.9)*,† | 29.5 (22.7–37.6) | 29.6 (23.5–37.1) | ||
| ms | 25 | 48.5 (27.2 to − 90.7)*,† | 48.8 (30.2–135.2) | 48 (25.8–100) | ||
| Normalized to length of diastole | ||||||
| | ms | 25 | 46 (38.4–54.4) | 47.5 (37.5–55.2)‡ | 46.3 (34.4–55.3) | |
| | ms | 25 | 61.5 (40.1–147) | 62.3 (43.4–138) | 66.7 (38–105.8) | 0.191 |
| | ms | 25 | 32.2 (26.3–49.3) | 32.6 (25.7–64)‡ | 32 (23.6 to − 52.5) | |
| | ms | 25 | 48.5 (27.2–90.7) | 48.8 (30.2–135.2) | 48 (25.8–100) | 0.225 |
| INCA raw analysis | ||||||
| | ms | 25 | 31.6 (26.3–40)*,† | 34.2 (28.7–43.1) | 35 (30.3–44) | |
| d | mmHg/sec | 25 | − 1321 (− 1648 to − 933) | − 1385 (− 1787 to − 934) | − 1394 (− 1757 to − 843) | 0.432 |
| Diastolic filling time | ms | 25 | 464 (302 to − 730) | 511 (266–730) | 528 (311–810) | |
| Peak filling rate | mL/s | 25 | 663 (352–1040) | 631 (442–1128) | 631 (437–1094) | 0.527 |
| Mid diastolic pressure at PFR | mmHg | 25 | 6.6 (0.2–11.7)*,† | 7.7 (− 0.5 to − 20.8) | 9.8 (2.4–15.7) | |
| EDP | mmHg | 25 | 15.3 (6.1–27.5) | 15.5 (4.4–26.8) | 15.9 (8.4–26.7) | 0.368 |
| EDV | ml | 25 | 166 (107–195) | 177 (107–210) | 159 (125–211) | 0.102 |
| ESP | mmHg | 25 | 127 (90–155) | 125 (93–173) | 129 (87–157) | 0.852 |
| ESV | ml | 25 | 57 (26 to − 93) | 66 (25–105) | 55 (36–109) | 0.228 |
p < 0.05, post-hoc Wilcoxon test: *0 vs. 5 cmH2O, †0 vs. 10 cmH2O, ‡5 vs. 10 cmH2O PEEP
ANOVA analysis of variance, PFR peak flow rate, EDP end-diastolic pressure, EDV end-diastolic volume, ESP end-systolic pressure, ESV end-systolic volume
p-values ≤0.05 were considered statistically significant and are indicated bold
Diastolic left heart pressure properties
| Positive end-expiratory pressure | Friedman ANOVA | |||||||
|---|---|---|---|---|---|---|---|---|
| 0 cmH2O | 5 cmH2O | 10cmH2O | ||||||
| Early diastolic | mmHg | 24 | 5.2 (0.13–9.5)*,† | 7.6 (1.2 to 12.8) | 6.7 (− 0.35 to 12.5) | |||
| Early diastolic, transmural | mmHg | 24 | − 1.3 (− 22–4.3) | − 2.1 (− 21 to 5.6) | − 2.7 (− 9.9 to 2.7) | 0.687 | ||
| Mid diastolic | mmHg | 25 | 8.9 (2.6–13.6)*,† | 10.4 (3.0 to 16.6) | 9.8 (0.9 to 14.6) | |||
| Mid diastolic, transmural | mmHg | 24 | 1.6 (− 19.8–7.7) | 0.35 (− 18.2 to 7.5) | − 0.93 (− 7.6 to 4.9) | 0.417 | ||
| Late diastolic | mmHg | 25 | 11.6 (4.1–24) | 12.8 (5.2 − 23.6) | 12.1 (3.6 to 21.8) | 0.167 | ||
| Late diastolic, transmural | mmHg | 24 | 2.7 (− 14.7–18) | 2.2 (− 17.4–13.9) | 1.4 (− 6.3–10.5) | 0.197 | ||
| Early diastolic | mmHg | 25 | 8.7 (− 0.2 to 13.8)*,† | 11.9 (6.2–18.2) | 10.4 (− 0.2 to 19.5) | |||
| Early diastolic, transmural | mmHg | 25 | 2.1 (− 18.3 10.6) | 1.5 (− 16 to 10) | 0.9 (− 18.8 to 12.5) | 0.846 | ||
| Mid diastolic | mmHg | 25 | 10.6 (− 0.2 to 18.8)† | 12.5 (8.9–21.1) | 12.6 (− 0.2 to 18.4) | |||
| Mid diastolic, transmural | mmHg | 25 | 3.6 (− 14.8 to 12.9) | 3.6 (− 14.4 to 8.9) | 2.2 (− 18.8 to 12.9) | 0.214 | ||
| Late diastolic | mmHg | 25 | 8.4 (− 0.23 to 16.6)*,† | 10.4 (7.7 to 20.7) | 11.2 (− 0.2 to 17.5) | |||
| Late diastolic, transmural | mmHg | 24 | 0.4 (− 13.6 to 7.8) | 1.7 (− 15.9 to 6.2) | 0.7 (− 19.5 to 11.9) | 0.747 | ||
| Early diastolic | mmHg | 24 | 3.7 (− 7.6 to 13.7) | 4.5 (− 1.7 to 11.3) | 3.8 (− 8.9 to 13.8) | 0.687 | ||
| Mid diastolic | mmHg | 24 | 2.9 (− 10.9 to 7.6) | 2.9 (− 2.3 to 9.2) | 2.9 (− 11.4 to 13.2) | 0.607 | ||
| Late diastolic | mmHg | 24 | − 3.0 (− 13.1 to 3.9) † | − 1.2 (− 9.5 to 4.9) | − 0.9 (− 13.2 to 9.6) | |||
p < 0.05, post-hoc Wilcoxon test: *0 vs. 5 cmH2O, †0 vs. 10 cmH2O, ‡5 vs. 10 cmH2O PEEP
ANOVA analysis of variance
p-values ≤ 0.05 were considered statistically significant and are indicated bold
Fig. 3a Left ventricular filling curves represented by diastolic ventricular pressure and PAOP, with 95% confidence intervals as dashed lines. The data were resampled for a filling period of 125 samples (500 ms). The dotted lines for early, mid- and late diastolic data points indicate the data presented in Table 4. b Transmural left ventricular filling curves Means with 95% confidence intervals as dashed lines are presented. The data were resampled to a filling period of 125 samples (500 ms). The dotted lines for early, mid- and late diastolic data points. PAOP pulmonary-artery occlusal pressure, LVP left ventricular pressure, PEEP positive end-expiratory pressure
Generalized linear mixed-effects model for EDPVR
| Coefficients | Std. err | 95% Confidence interval | ||
|---|---|---|---|---|
| EDPVR (atmospheric reference) | ||||
| ln Intercept for PEEP 0 cmH2O at the mean volume (136.2 mL) | 2.26 | 0.09 | < 0.001 | 2.09–2.43 |
| Changes in ln of intercepts | ||||
| PEEP 5 | 0.08 | 0.03 | 0.015 | 0.01–0.14 |
| PEEP 10 | 0.27 | 0.03 | < 0.001 | 0.21–0.34 |
| ln Slope coefficient PEEP 0 cmH2O | 0.02 | 0.00 | < 0.001 | 0.01–0.02 |
| Changes in ln of slope coefficients | ||||
| PEEP 5 cmH2O | − 0.003 | 0.0008 | < 0.001 | − 0.005 to − 0.001 |
| PEEP 10 cmH2O | − 0.004 | 0.0008 | < 0.001 | − 0.005–0.002 |
| EDPVR (transmural pressure) | ||||
| ln Intercept for PEEP 0 at the mean volume (136.2 mL) | 1.55 | 0.14 | < 0.001 | 1.27–1.84 |
| Changes in ln of intercepts | ||||
| PEEP 5 | − 0.21 | 0.07 | 0.001 | − 0.34 to − 0.08 |
| PEEP 10 | − 0.25 | 0.06 | < 0.001 | − 0.37 to − 0.14 |
| ln Slope coefficient for PEEP 0 | 0.02 | 0.003 | < 0.001 | 0.009–0.02 |
| Changes in ln of slope coefficients | ||||
| PEEP 5 | 0.002 | 0.002 | 0.337 | − 0.005 to 0.002 |
| PEEP 10 | 0.003 | 0.002 | 0.094 | − 0.0004 to 0.006 |
All values are given as natural logarithms
EDPVR end-diastolic pressure volume relationship, PEEP positive end-expiratory pressure
Fig. 4a End-systolic pressure–volume relationships (ESPVRs) for 0, 5, and 10 cmH2O PEEP, according to the mixed linear model equations in Table 4. The equation values are reported at the mean centered volume (50.4 ml), indicated by the dotted line. b End-diastolic pressure–volume relationships (EDPVRs), according to the mixed-effect generalized linear model equations in Table 7. The equation values are reported at the mean centered volume (136.2 ml), indicated by the dotted line. PEEP positive end-expiratory pressure
Echocardiographic diastology parameters
| Positive end-expiratory pressure | Friedman | |||||
|---|---|---|---|---|---|---|
| 0cmH2O | 5cmH2O | 10cmH2O | ||||
| m/s | 25 | 0.77 (0.53–1.04)† | 0.76 (0.49–1.05) | 0.66 (0.5–0.94) | ||
| DecT | ms | 25 | 189 (111–300) | 183 (131–331) | 187 (114–306) | 0.756 |
| m/s | 24 | 0.73 (0.53–1.02)† | 0.71 (0.5–0.99)‡ | 0.63 (0.44–1) | ||
| 23 | 1.12 (0.62–1.45) | 1.05 (0.66–1.56) | 1.09 (0.66–1.38) | 0.438 | ||
| ms | 25 | 956 (717–1194)*,† | 993 (765–1259) | 960 (758–1205) | ||
| Diastole | ms | 25 | 555 (357–790)*,† | 606 (384–853) | 600 (376–806) | |
| Diastole/ | % | 25 | 58 (49–66)*,† | 62 (50–68) | 61 (48–72) | |
| Edur | ms | 22 | 251 (168–362)† | 252 (188–398) | 261 (176–379) | |
| Edur/ | % | 22 | 25.2 (18.6–35.1) | 24.7 (20–37.6) | 26.6 (20.1–35.7) | 0.834 |
| Edur/diastole | % | 22 | 44.5 (30.1–55) | 41.4 (32–55.3) | 44.1 (31.2 (54.7) | 0.554 |
| Adur | ms | 22 | 131 (94–161) | 137 (94–162) | 135 (101–166) | 0.386 |
| Adur/ | % | 22 | 14.3 (7.9–16.4) | 13.6 (8.6–17.4) | 13.7 (9.5–15.8) | 0.58 |
| Adur/diastole | % | 22 | 24.4 (11.9–30) | 22 (13.6–29.7) | 22.6 (14.3–28.4) | 0.554 |
| m/s | 24 | 0.082 (0.06–0.13)*,† | 0.08 (0.06–0.12) | 0.076 (0.05–0.1) | ||
| m/s | 25 | 0.11 (0.08–0.15) | 0.11 (0.076 to 0.13) | 0.11 (0.06–0.16) | 0.647 | |
| 23 | 7.2 (5.5–11.8) | 8.0 (5.3–10.8) | 7.4 (4.4–13.2) | 0.17 | ||
| ms | 24 | 963 (732–1165) | 991 (743–1203) | 993 (780–1265) | 0.197 | |
| m/s | 24 | 0.085 (0.046–0.14) | 0.086 (0.06–0.12) | 0.080 (0.04–0.13) | 0.3 | |
| m/s | 25 | 0.096 (0.07–0.14)† | 0.0.093 (0.06–0.13) | 0.083 (0.05–0.16) | ||
| IVRT | ms | 24 | 66.7 (47–92.3)*,† | 79 (34.6–102.6) | 82 (48–115.3) | |
| IVRT/ | % | 24 | 7 (4.7–9.5)† | 7.8 (3.8–11.2) | 8.2 (5.1–13) | |
p < 0.05, post-hoc Wilcoxon test: *0 vs. 5 cmH2O, †0 vs. 10 cmH2O, ‡5 vs. 10 cmH2O PEEP
E early ventricular filling wave, DecT deceleration time, A atrial ventricular filling wave, Edur E wave duration, Adur A wave duration, IVRT isovolumetric relaxation time, PW pulse wave Doppler mode
p-values ≤0.05 were considered statistically significant and are indicated bold